Streptococcal skin infection and rheumatic heart disease

Current Opinion in Infectious Diseases

Volumn 25, Issue 2, 2012, Pages 145-153

  Parks, Tom ^a   Smeesters, Pierre R ^b,c   Steer, Andrew C ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

acute rheumatic fever; group A streptococcus; impetigo; rheumatic heart disease; Streptococcus pyogenes

Indexed keywords

IVERMECTIN; PENICILLIN G;

ANTIBIOTIC THERAPY; BACTERIUM ISOLATION; DISEASE SURVEILLANCE; ECHOCARDIOGRAPHY; GROUP A STREPTOCOCCAL INFECTION; GROUP A STREPTOCOCCAL SKIN INFECTION; HOST SUSCEPTIBILITY; HUMAN; IMPETIGO; INFECTION PREVENTION; INFECTION RISK; OUTCOME ASSESSMENT; PATHOGENESIS; PHARYNGITIS; RECURRENT DISEASE; REVIEW; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; RISK FACTOR; SCABIES; SKIN INFECTION; THROAT CULTURE;

DEVELOPING COUNTRIES; HUMANS; IMPETIGO; PREVALENCE; RHEUMATIC HEART DISEASE; SKIN DISEASES, BACTERIAL; STREPTOCOCCAL INFECTIONS; TROPICAL CLIMATE;

EID: 84858006447     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3283511d27     Document Type: Review

References (112)

1. World Health Organization. Epidemiology and management of common skin diseases in children in developing countries. Geneva: World Health Organization; 2005.
2. Bernard P. Management of common bacterial infections of the skin. Curr Opin Infect Dis 2008; 21:122-128. (Pubitemid 351641513)
3. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005; 5:685-694. (Pubitemid 41505357)
4. Hay RJ, Estrada Castanon R, Alarcon Hernandez H, et al. Wastage of family income on skin disease in Mexico. BMJ 1994; 309:848. (Pubitemid 24305011)
5. Mahe A, Prual A, Konate M, Bobin P. Skin diseases of children in Mali: a public health problem. Trans R Soc Trop Med Hyg 1995; 89:467-470.
6. Carapetis JR, Walker AM, Hibble M, et al. Clinical and epidemiological features of group A streptococcal bacteraemia in a region with hyperendemic superficial streptococcal infection. Epidemiol Infect 1999; 122:59-65. (Pubitemid 29080404)
7. Skull SA, Krause V, Coombs G, et al. Investigation of a cluster of Staphylococcus aureus invasive infection in the top end of the Northern Territory. Aust N Z J Med 1999; 29:66-72. (Pubitemid 29136659)
8. Holm S, Nordstrand A, Stevens D, Norgren M. Acute poststreptococcal glomeruloneprhitis. In: Stevens D, Kaplan EL, editors. Streptococcal infections: clinical aspects, microbiology and molecular pathogenesis. New York: Oxford University Press; 2000. pp. 152-162.
9. McDonald M, Currie BJ, Carapetis JR. Acute rheumatic fever: a chink in the chain that links the heart to the throat? Lancet Infect Dis 2004; 4:240-245. (Pubitemid 38407307)
10. Bechelli LM, Haddad N, Pimenta WP, et al. Epidemiological survey of skin diseases in schoolchildren living in the Purus Valley (Acre State, Amazonia, Brazil). Dermatologica 1981; 163:78-93. (Pubitemid 11094547)
11. Belcher DW, Afoakwa SN, Osei-Tutu E, et al. Endemic pyoderma in Ghana: a survey in rural villages. Trans R Soc Trop Med Hyg 1977; 71:204-209. (Pubitemid 8126903)
12. Carapetis JR, Connors C, Yarmirr D, et al. Success of a scabies control program in an Australian aboriginal community. Pediatr Infect Dis J 1997; 16:494-499. (Pubitemid 27212787)
13. Lawrence DN, Facklam RR, Sottnek FO, et al. Epidemiologic studies among Amerindian populations of Amazonia. I. Pyoderma: prevalence and associated pathogens. Am J Trop Med Hyg 1979; 28:548-558. (Pubitemid 9210508)
14. el Tayeb SH, Nasr EM, Sattallah AS. Streptococcal impetigo and acute glomerulonephritis in children in Cairo. Br J Dermatol 1978; 98:53-62. (Pubitemid 8283718)
15. Nsanzumuhire H, Taplin D, Lansdell L. Pyoderma among Ugandan children. East Afr Med J 1972; 49:84-88.
16. Tewodros W, Muhe L, Daniel E, et al. A one-year study of streptococcal infections and their complications among Ethiopian children. Epidemiol Infect 1992; 109:211-225.
17. Anthony BF, Perlman LV, Wannamaker LW. Skin infections and acute nephritis in American Indian children. Pediatrics 1967; 39:263-279.
18. Dillon HC. Impetigo contagiosa: suppurative and nonsuppurative complications I: clinical, bacteriologic, and epidemiologic characteristics of impetigo. Am J Dis Child 1968; 115:530-541.
19. Masawe AEJ, Nsanzumuhire H, Mhalu F. Bacterial skin infections in preschool and school-children in coastal Tanzania. Arch Derm 1975; 111:1312-1316.
20. Olumide YM, Oresanya DF, Saliu AA. The management of pyodermas. Int J Dermatol 1987; 26:544-546.
21. Suite M. Cutaneous infections in Trinidad. Int J Dermatol 1990; 29: 31-34. (Pubitemid 20136318)
22. Currie BJ, Carapetis JR. Skin infections and infestations in Aboriginal communities in northern Australia. Australas J Dermatol 2000; 41:139-143; quiz 44-45.
23. Dajani AS, Ferrieri P, Wannamaker L. Endemic superficial pyoderma in children. Arch Dermatol 1973; 108:517-522.
24. Dajani AS, Ferrieri P, Wannamaker LW. Natural history of impetigo II: etiologic agents and bacterial interactions. J Clin Invest 1972; 51:2863-2871.
25. Sugeng MW, Ang P, Tan HH, Goh CL. Characteristics of bacterial skin infections in children compared to adults at a tertiary dermatologic center. Int J Dermatol 1999; 38:582-586. (Pubitemid 29404787)
26. Steer AC, Jenney AW, Kado J, et al. High burden of impetigo and scabies in a tropical country. PLoS Negl Trop Dis 2009; 3:e467.
27. World Health Organization. Rheumatic fever and rheumatic heart disease. World Health Organization Tech Rep Ser 2004; 923:1-122.
28. Kaplan EL, Bisno AL. Antecedent streptococcal infection in acute rheumatic fever. Clin Infect Dis 2006; 43:690-692. (Pubitemid 44330729)
29. Steer AC, Carapetis JR. Acute rheumatic fever and rheumatic heart disease in indigenous populations. Pediatr Clin North Am 2009; 56:1401-1419.
30. Steer AC, Kado J, Jenney AW, et al. Acute rheumatic fever and rheumatic heart disease in Fiji: prospective surveillance, 2005-2007. Med J Aust 2009; 190:133-135.
31. Steer AC, Kado J, Wilson N, et al. High prevalence of rheumatic heart disease by clinical and echocardiographic screening among children in Fiji. J Heart Valve Dis 2009; 18:327-335.
32. Steer AC, Jenney AW, Kado J, et al. Prospective surveillance of streptococcal sore throat in a tropical country. Pediatr Infect Dis J 2009; 28:477-482.
33. Steer AC, Adams J, Carlin J, et al. Rheumatic heart disease in school children in Samoa. Arch Dis Child 1999; 81:372.
34. Carapetis JR, Wolff DR, Currie BJ. Acute rheumatic fever and rheumatic heart disease in the top end of Australia's Northern Territory.Med J Australia 1996; 164:146-149. (Pubitemid 26051106)
35. McDonald MI, Towers RJ, Andrews RM, et al. Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian Aboriginal communities where acute rheumatic fever is hyperendemic. Clin Infect Dis 2006; 43:683-689. (Pubitemid 44330728)
36. Parks T, Kado J, Colquhoun S, et al. Underdiagnosis of acute rheumatic fever in primary care settings in a developing country. Trop Med Int Health 2009; 14:1407-1413.
37. Garrod AE. A Discussion on tonsillitis, its varieties and relations to rheumatism. II. Br Med J 1889; 2:584-586.
38. Collis WRF. Bacteriology of rheumatic fever. Lancet 1939; 234:817-820.
39. Glover JA. Milroy Lectures on the incidence of rheumatic diseases I: the incidence of acute rheumatism. Lancet 1930; 215:499-505.
40. Glover JA, Griffith F. Acute tonsillitis and some of its sequels: epidemiological and bacterial observations. Br Med J 1931; 2:521-527.
41. Collis WRF. Acute rheumatism and haemolytic streptococci. Lancet 1931; 217:1341-1345.
42. Sheldon W. On acute rheumatism following tonsillitis. Lancet 1931; 217:1337-1341.
43. Coburn AF, Pauli RH. Studies of the relationship of the Streptococcus hemolyticus to the rheumatic process: I. Observations of the ecology of hemolytic streptococcus in relation to the epidemiology of rheumatic fever. J Exp Med 1932; 56:609-632.
44. Denny FW. A 45-year perspective on the streptococcus and rheumatic fever: the Edward H. Kass Lecture in infectious disease history. Clin Infect Dis 1994; 19:1110-1122.
45. Robertson KA, Volmink JA, Mayosi BM. Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc Disord 2005; 5:11.
46. Cheadle WB. Barbeian Lectures on the various manifestations of the rheumatic state as exemplified in childhood and early life. Lancet 1889; 133:821-827.
47. Whipham T. Reports of the Collective Investigation Committee of the British Medical Association. Report on Inquiry No. III. Acute rheumatism. Br Med J 1888; i:387.
48. Wannamaker LW. Differences between streptococcal infections of the throat and of the skin (second of two parts). N Engl J Med 1970; 282:78-85.
49. Wannamaker LW. Differences between streptococcal infections of the throat and of the skin (first of two parts). N Engl J Med 1970; 282:23-31.
50. Bisno AL, Pearce IA, Wall HP, et al. Contrasting epidemiology of acute rheumatic fever and acute glomerulonephritis: nature of antecedent streptococcal infection. N Engl J Med 1970; 283:561-565.
51. Seegal D, Earle DP. A consideration of certain biological differences between glomerulonephritis and rheumatic fever. Am J Med Sci 1941; 201:528-539.
52. Coulehan J, Grant S, Reisinger K, et al. Acute rheumatic-fever and rheumatic heart-disease on the Navajo Reservation, 1962-1977. Public Health Rep 1980; 95:62-68. (Pubitemid 10095521)
53. Kaplan EL, Anthony BF, Chapman SS, et al. The influence of the site of infection on the immune response to group A streptococci. J Clin Invest 1970; 49:1405-1414.
54. Wannamaker LW. The chain that links the heart to the throat. Circulation 1973; 48:9-18.
55. Lancefield R. The antigenic complex of Streptococcus hemolyticus: I. Demonstration of a type-specific substance in extracts of Streptococcus hemolyticus. J Exp Med 1928; 47:91-103.
56. Pauli RH, Coburn AF. With the assistance of Florence Stone PD. Studies on the serological typing of Streptococcus hemolyticus. J Exp Med 1937; 65:595-612.
57. Facklam R, Beall B, Efstratiou A, et al. emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis 1999; 5:247-253. (Pubitemid 29200623)
58. Lancefield RC. Current knowledge of type-specific M antigens of group A streptococci. J Immunol 1962; 89:307-313.
59. Smeesters PR, McMillan DJ, Sriprakash KS. The streptococcal M protein: a highly versatile molecule. Trends in microbiology 2010; 18:275-282. An up to date review of the GAS M protein and its structure and function.
60. Dillon HC, Derrick CW, Dillon MS. M-antigens common to pyoderma and acute glomerulonephritis. J Infect Dis 1974; 130:257-267.
61. Bessen D, Jones KF, Fischetti VA. Evidence for 2 distinct classes of streptococcal M-protein and their relationship to rheumatic fever. J Exp Med 1989; 169:269-283. (Pubitemid 19035556)
62. Bessen DE, Sotir CM, Readdy TL, Hollingshead SK. Genetic correlates of throat and skin isolates of group A streptococci. J Infect Dis 1996; 173:896-900. (Pubitemid 26176012)
63. Bessen DE, Lizano S. Tissue tropisms in group A streptococcal infections. Future Microbiol 2010; 5:623-638. This contemporary article examines key features of the epidemiology, population biology and molecular pathogenesis that underlie the tissue site preferences for infection exhibited by GAS.
64. Veasy LG, Wiedmeier SE, Orsmond GS, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 1987; 316:421-427. (Pubitemid 17035568)
65. Smoot JC, Barbian KD, Van Gompel JJ, et al. Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci USA 2002; 99:4668-4673. (Pubitemid 34286042)
66. Smoot JC, Korgenski EK, Daly JA, et al. Molecular analysis of group A streptococcus type emm18 isolates temporally associated with acute rheumatic fever outbreaks in Salt Lake City, Utah. J Clin Microbiol 2002; 40:1805-1810. (Pubitemid 34493161)
67. Miner LJ, Petheram SJ, Daly JA, et al. Molecular characterization of Streptococcus pyogenes isolates collected during periods of increased acute rheumatic fever activity in Utah. Pediatr Infect Dis J 2004; 23:56-61. (Pubitemid 38176763)
68. World Health Organization. Prevention of rheumatic fever. Report of a WHO Expert Committee World Health Organization Technical Report Series. 1966; 342:1-30.
69. Bessen DE, Carapetis JR, Beall B, et al. Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of the skin and throat. J Infect Dis 2000; 182:1109-1116.
70. Potter EV, Svartman M, Mohammed I, et al. Tropical acute rheumatic-fever and associated streptococcal infections compared with concurrent acute glomerulonephritis. J Pediatr 1978; 92:325-333. (Pubitemid 8293984)
71. Martin DR, Voss LM, Walker SJ, et al. Acute rheumatic fever in Auckland, New-Zealand: spectrum of associated group A streptococci different from expected. Pediatr Infect Dis J 1994; 13:264-269. (Pubitemid 24113355)
72. MacCormac H. Primary and secondary impetigo in soldiers. Br Med J 1918; 1:143-144.
73. Newman JL. Impetigo contagiosa, its epidemiology and control. J Hyg (Lond) 1935; 35:150-159.
74. Radcliffe Crocker H. The Lettsomian Lectures on the conditions which modify the characters of inflammations of the skin, and their influence on treatment. Lancet 1903; 161:491.
75. Shaw TB. Remarks on the incidence, aetiology and prevention of rheumatic fever in the navy. Proc R Soc Med 1925; 18(War Sect):9-16.
76. Veasy LG, Tani LY, Hill HR. Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr 1994; 124:9-16. (Pubitemid 24027280)
77. Lennon D, Stewart J, Farrell E, et al. School-based prevention of acute rheumatic fever: a group randomized trial in New Zealand. Pediatr Infect Dis J 2009; 28:787-794.
78. Steer AC, Law I, Matatolu L, et al. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 2009; 9:611-616.
79. Smeesters PR, McMillan DJ, Sriprakash KS, Georgousakis MM. Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines? Expert Rev Vaccin 2009; 8:1705-1720.
80. Steer AC, Magor G, Jenney AW, et al. emm and C-repeat region molecular typing of beta-hemolytic Streptococci in a tropical country: implications for vaccine development. J Clin Microbiol 2009; 47:2502-2509.
81. Erdem G, Mizumoto C, Esaki D, et al. Streptococcal emm types in Hawaii: a region with high incidence of acute rheumatic fever. Pediatr Infect Dis J 2009; 28:13-16.
82. Smeesters PR, Vergison A, Campos D, et al. Differences between Belgian and Brazilian Group A streptococcus epidemiologic landscape. Plos One 2006; e10.
83. Smeesters PR, Dramaix M, Van Melderen L. The emm-type diversity does not always reflect the M protein genetic diversity: is there a case for designer vaccine against GAS. Vaccine 2010; 28:883-885. This article presents interesting preliminary data that challenges the previously held view that there are diverse strains of GAS in tropical countries.
84. Smeesters PR, Mardulyn P, Vergison A, et al. Genetic diversity of group A streptococcus M protein: implications for typing and vaccine development. Vaccine 2008; 26:5835-5842.
85. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet 2005; 366:155-168. (Pubitemid 40991218)
86. Tewodros W, Kronvall G. M protein gene (emm type) analysis of group a beta-hemolytic streptococci from Ethiopia reveals unique patterns. J Clin Microbiol 2005; 43:4369-4376. (Pubitemid 41298215)
87. Erdem G, Mizumoto C, Esaki D, et al. Group a streptococcal isolates temporally associated with acute rheumatic fever in Hawaii: differences from the continental United States. Clin Infect Dis 2007; 45:E20-E24.
88. Dhanda V, Sagar V, Vihra H, et al. emm-type distribution of group A streptococcus (GAS) in North Indian from 1995-2010: Need for a new preventive approach. XVIII Lancefield International Symposium 2011; Palermo, Italy; 2011. p. 17.
89. Kumar R, Vohra H, Chakraborty A, et al. Epidemiology of group A streptococcal pharyngitis and impetigo: a cross-sectional and follow up study in a rural community of northern India. Indian J Med Res 2009; 130:765-771.
90. Rheumatic fever and rheumatic heart disease: report of a WHO Expert Consultation Geneva. Geneva: World Health Organisation; 2004.
91. Bisno AL, Rubin FA, Cleary PP, Dale JB. Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles - report of a National Institute of Allergy and Infectious Diseases workshop. Clin Infect Dis 2005; 41:1150-1156. (Pubitemid 41429478)
92. Svensson MD, Sjobring U, Luo F, Bessen DE. Roles of the plasminogen activator streptokinase and the plasminogen-associated M protein in an experimental model for streptococcal impetigo. Microbiology 2002; 148 (Pt 12):3933-3945. (Pubitemid 36097455)
93. Kalia A, Bessen DE. Natural selection and evolution of streptococcal virulence genes involved in tissue-specific adaptations. J Bacteriol 2004; 186:110-121. (Pubitemid 38020293)
94. McGregor KF, Spratt BG, Kalia A, et al. Multilocus sequence typing of Streptococcus pyogenes representing most known emm types and distinctions among subpopulation genetic structures. J Bacteriol 2004; 186:4285-4294. (Pubitemid 38802577)
95. McGregor KF, Bilek N, Bennett A, et al. Group A streptococci from a remote community have novel multilocus genotypes but share emm types and housekeeping alleles with isolates from worldwide sources. J Infect Dis 2004; 189:717-723. (Pubitemid 38270927)
96. Bessen DE, Kumar N, Hall GS, et al. Whole-genome association study on tissue tropism phenotypes in group a streptococcus. J Bacteriol 2011; 193:6651-6663. This study describes major genetic changes associated with adaptation of GAS when it infects the skin and throat.
97. Guilherme L, Kalil J, Cunningham MW. Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity 2006; 39:31-39. (Pubitemid 43878518)
98. Guilherme L, Cury P, Demarchi LMF, et al. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am J Pathol 2004; 165:1583-1591. (Pubitemid 39435157)
99. Roberts S, Kosanke S, Terrence Dunn S, et al. Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. J Infect Dis 2001; 183:507-511. (Pubitemid 32105611)
100. Guilherme L, Fae K, Vigna F, et al. Rheumatic heart disease: inflmammtory molecules drive T cell infiltration into the heart valves. XVIII Lancefield International Symposium; Palermo, Italy; 2011.
101. Guilherme L, Ramasawmy R, Kalil J. Rheumatic fever and rheumatic heart disease: genetics and pathogenesis. Scand J Immunol 2007; 66:199-207. (Pubitemid 47064375)
102. Guilherme L, Kalil J. Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease. J Clin Immunol 2010; 30:17-23. A review of the pathogenesis of rheumatic fever with a focus on genes that confer susceptibility as well as a discussion of the innate and adaptive immune responses against GAS during the rheumatic fever episode.
103. Dileepan T, Linehan JL, Moon JJ, et al. Robust antigen specific Th17 T cell response to group A streptococcus is dependent on IL-6 and intranasal route of infection. PLoS Pathog 2011; 7:e1002252. New in-vitro mouse data that describes the role of IL-17 and interferon gamma producing CD4+ T cells in maintaining carriage of GAS at the pharynx.
104. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996; 272:60-66. (Pubitemid 26110755)
105. MSD Wellcome Trust Hilleman Laboratories. Developing vaccines for global health: group A streptococci. New Delhi; 2010.
106. Lee JC, Parkes M. Genome-wide association studies and Crohn's disease. Brief Funct Genom Proteom 2011; 10:71-76. A summary of the principal discoveries that have been made in Crohn's disease genetics and how these discoveries have improved understanding of disease pathogenesis.
107. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447:661-678.
108. Engel ME, Stander R, Vogel J, et al. Genetic susceptibility to acute rheumatic fever: a systematic review and meta-analysis of twin studies. Plos One 2011; 6:e25326. A systematic review and meta-analysis of twin studies of concordance of acute rheumatic fever in order to derive quantitative estimates of the size of the genetic effect.
109. Steer AC, Carapetis JR, Nolan TM, Shann F. Systematic review of rheumatic heart disease prevalence in children in developing countries: the role of environmental factors. J Paediatr Child H 2002; 38:229-234. (Pubitemid 34592176)
110. Carapetis JR, Currie BJ. Group A streptococcus, pyoderma, and rheumatic fever. Lancet 1996; 347:1271-1272. (Pubitemid 26131882)
111. Fox LM. Ivermectin: uses and impact 20 years on. Curr Opin Infect Dis 2006; 19:588-593. (Pubitemid 44665466)
112. Lawrence GW, Leafasia J, Sheridan J, et al. Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull World Health Organ 2005; 83:34-42.